Bioptimus and Proscia Webinar: Unlocking the Promise of Foundation ModelsWATCH

Proscia’s Digital Pathology System Obtains CE Mark

Proscia
By Author Proscia | November 7, 2019

Proscia has received a CE Mark for its Concentriq Dx solution for use in primary diagnosis. The CE Mark indicates that Concentriq Dx complies with the European In Vitro Diagnostic Regulations. Read more here:

Our website uses cookies. By using this site, you agree to its use of cookies.